Form4insider filings, from the source

SEC Form 4 · accession 0001127602-16-041406

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Alan J Main
Officer — EVP, CMC and Supply Operations
Period of report
Feb 11, 2016
Accepted (ET)
Feb 16, 2016 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———27,147D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$8.20Feb 11, 2016A65,340A—Feb 11, 2026Common Stock65,34065,340D
Restricted Stock Units (Phantom Stock)F2,F3—Feb 11, 2016A16,340A——Common Stock16,34016,340D
Stock Option (Right to Buy)F4$12.67holding————Feb 23, 2021Common Stock37,14237,142D
Stock Option (Right to Buy)F5$12.60holding————Feb 15, 2022Common Stock39,99939,999D
Restricted Stock Units (Phantom Stock)F2,F6—holding—————Common Stock2,5002,500D
Stock Option (Right to Buy)F7$14.63holding————Feb 8, 2023Common Stock37,71337,713D
Restricted Stock Units (Phantom Stock)F2,F8—holding—————Common Stock4,7144,714D
Stock Option (Right to Buy)F9$12.04holding————Feb 6, 2024Common Stock42,85642,856D
Restricted Stock Units (Phantom Stock)F2,F10—holding—————Common Stock8,0358,035D
Stock Option (Right to Buy)F11$6.23holding————Feb 5, 2025Common Stock84,34284,342D
Restricted Stock Units (Phantom Stock)F2,F12—holding—————Common Stock21,08521,085D
Stock Option (Right to Buy)F13$27.58holding————Feb 13, 2017Common Stock14,28514,285D
Stock Option (Right to Buy)F14$14.49holding————Feb 7, 2018Common Stock28,57028,570D
Stock Option (Right to Buy)F15$10.15holding————Feb 12, 2019Common Stock46,42746,427D
Stock Option (Right to Buy)F16$13.30holding————Feb 15, 2020Common Stock46,42846,428D

Explanation of responses